Log in to search using one of your social media accounts:

 

Addictive Opioids Common for People on Dialysis
But dose of pain-killing drugs often too high, researchers say Source: HealthDay Related MedlinePlus Pages: Dialysis, Opioid Abuse and Addiction, Pain Relievers (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - September 22, 2017 Category: Consumer Health News Source Type: news

Opioid Use High Among Dialysis Patients (CME/CE)
(MedPage Today) -- Chronic use associated with all-cause mortality and hospitalization (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - September 21, 2017 Category: American Health Source Type: news

Addictive Opioids Common for People on Dialysis
THURSDAY, Sept. 21, 2017 -- Kidney dialysis patients in the United States have high rates of prescriptions for opioid painkillers and many also receive high doses of the potentially addictive drugs, a new study finds. Pain is common in dialysis... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 21, 2017 Category: General Medicine Source Type: news

How first ‘vouchers’ in UCLA kidney donation program led to 25 lifesaving transplants
In 2014 a former judge from San Diego County approached the UCLA Kidney Transplant Program with an unusual request: If the judge donated a kidney to a stranger now, could his then-4-year-old grandson, who suffered from chronic kidney disease, receive priority for a future kidney transplant if needed later in life?The suggestion from Howard Broadman, then 64 years old, initiated the kidney “voucher” program, an innovative system allowing living donors to donate a kidney now, or at some time in the near future, allowing a family member or friend to be given priority for a kidney transplant in the future if needed...
Source: UCLA Newsroom: Health Sciences - September 19, 2017 Category: Universities & Medical Training Source Type: news

CIRSE 2017 Round-up: Delcath touts second-gen hemofiltration system in percutaneous hepatic perfusion
Delcath Systems (NSDQ:DCTH) touted data today from a study of its second-generation hemofiltration system in patients undergoing percutaneous hepatic perfusion with melphalan hydrochloride. The New York-based company presented the results from its study at the Cardiology and Interventional Radiology of Europe annual meeting in Copenhagen, Denmark. The investigational product, an injectable melphalan hydrochloride for use with Delcath’s hepatic delivery system, is designed to administer high-dose chemotherapy to the liver while limiting systemic exposure and side effects. Get the full story at our sister site, Dr...
Source: Mass Device - September 19, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Oncology Pharmaceuticals Wall Street Beat Delcath Systems Inc. Source Type: news

Stronger Health Systems Can Provide Palestinians with Better Health Care
September 18, 2017Improvements can help Palestinians access better health care today —and prepare for the unknowns of tomorrow.Outside the Palestinian Medical Complex in Ramallah, I saw a woman emerge from the crowd. She looked frantic with worry and purpose as she approached.She needed the doctor who was accompanying me, or rather his signature on a referral form —a formality that stood between her and the specialized health care she, or perhaps a loved one, needed.I was there last month to visit ourPalestinian Health Capacity Project, which is doing crucial and challenging work to help the Palestinian Ministr...
Source: IntraHealth International - September 18, 2017 Category: International Medicine & Public Health Authors: intrahealth Source Type: news

WATCH: Mother of 5 donates kidney to single mom
Jenny Williams of Memphis, Tennessee, donated one of her kidneys to Erica Walker, a single mom who was facing dialysis. (Source: ABC News: Health)
Source: ABC News: Health - September 18, 2017 Category: Consumer Health News Tags: Lifestyle Source Type: news

7 medtech stories we missed this week: Sept. 15, 2017
[Image from unsplash.com]From Acera Surgical and Telos Medical’s partnership to Xtant Medical’s 510(k) clearance, here are seven medtech stories we missed this week but thought were still worth a mention. 1. Acera Surgical partners with Telos Medical for Restrata wound matrix trial Telos Partners announced in a Sept. 14 press release that Acera Surgical has chosen Telos to lead its Restrata wound matrix study. The study will surgery the clinical outcomes of Restrata treatments for diabetic foot ulcers and test for effectiveness and safety. Restrata is a fully synthetic wound matrix that is FDA-cleared for ...
Source: Mass Device - September 15, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Business/Financial News Clinical Trials Dental Diagnostics Food & Drug Administration (FDA) Regulatory/Compliance Surgical Acera Surgical Contego Medical Fresenius MedTech OBP Medical Pinnacle Sciences Plusoptix Telos Source Type: news

Nutritional Considerations for Older Patients on Dialysis Nutritional Considerations for Older Patients on Dialysis
This report highlights the special considerations regarding the nutritional needs of aging hemodialysis patients.Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 15, 2017 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

AlloSource touts completion of bioengineered blood vessels for Humacyte trial
Tissue-provider AlloSource said this week it completed production of investigational bioengineered blood vessels designed for Humacyte‘s Phase III clinical trial exploring the use of the vessels to improve vascular access for hemodialysis patients with end-stage renal failure. The trail aims to compare the efficacy of the bioengineered human-tissue vessels to current synthetic vessels made from expanded polytetrafluoroethylene, Centennial, Colo.-based Allosource said. “AlloSource’s partnership with Humacyte supports our focus on regenerative medicine. Our organizations share a deep commitment to developin...
Source: Mass Device - September 14, 2017 Category: Medical Devices Authors: Fink Densford Tags: Research & Development Vascular allosource Humacyte Source Type: news

Information for Disaster Evacuation Centers
Centers for Disease Control and Prevention. 09/05/2017 This Web page, updated in September 2017, contains links to information for evacuation centers, including infection control, medical management and patient advisement, glucose monitoring, dialysis care after a disaster, and disaster information for pet centers. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - September 13, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Tags: Evacuation and Relocation--Individual Behavior--Communicable Disease Control Source Type: news

If you need a dialysis after #HurricaneIrma, talk to your regular provider first. If you can ’ t get in, call the @KCERprograms Helpline.pic.twitter.com/0pcOMZHARb
If you need a dialysis after #HurricaneIrma, talk to your regular provider first. If you can’t get in, call the @KCERprograms Helpline. pic.twitter.com/0pcOMZHARb (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - September 13, 2017 Category: Medical Devices Authors: ( at PHEgov) Source Type: news

Predictors of acute kidney injury after paraquat intoxication - Weng CH, Chen HH, Hu CC, Huang WH, Hsu CW, Fu JF, Lin WR, Wang IK, Yen TH.
Paraquat intoxication is characterized by multi-organ failure, causing substantial mortality and morbidity. Many paraquat patients experience acute kidney injury (AKI), sometimes requiring hemodialysis. We observed 222 paraquat-intoxicated patients between... (Source: SafetyLit)
Source: SafetyLit - September 13, 2017 Category: International Medicine & Public Health Tags: Poisoning Source Type: news

Puerto Rico Takes Post-Irma Dialysis Patients
(MedPage Today) -- Also, societies gather supplies for diabetic patients (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - September 12, 2017 Category: Consumer Health News Source Type: news

Irma Blows Out of Florida After Emptying 30 Hospitals Irma Blows Out of Florida After Emptying 30 Hospitals
Meanwhile, HHS and military personnel are searching for dialysis patients in badly battered St Thomas in the US Virgin Islands --'under grueling conditions'-- and flying them to Puerto Rico.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 11, 2017 Category: Consumer Health News Tags: Emergency Medicine News Source Type: news

SEIU raises ballot proposal as alternative for dialysis bills
The two bills would have imposed staffing and spending requirements on dialysis clinics throughout the state. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 8, 2017 Category: Pharmaceuticals Authors: Scott Rodd Source Type: news

SEIU raises ballot proposal as alternative for dialysis bills
The two bills would have imposed staffing and spending requirements on dialysis clinics throughout the state. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 8, 2017 Category: Biotechnology Authors: Scott Rodd Source Type: news

High-Protein Meals and Lanthanum Carbonate in Hemodialysis High-Protein Meals and Lanthanum Carbonate in Hemodialysis
What benefits might an increased protein intake combined with lanthanum carbonate offer hemodialysis patients?Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 8, 2017 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Shoeshine man gets 'amazing' tip of a lifetime — a new kidney
A Calgary shoeshine man was in failing health, on dialysis and almost unable to work, until one of his longtime customers put his best foot forward. (Source: CBC | Health)
Source: CBC | Health - September 7, 2017 Category: Consumer Health News Tags: News/Canada/Calgary Source Type: news

Dialysis bills in California Legislature head to floor for votes
Two bills that would impose increased regulation on dialysis clinics in California are headed to floor votes in both houses of the Legislature. Assembly Bill 251, introduced by Assemblyman Rob Bonta, D-Oakland, would require dialysis clinics to spend at least 85 percent of treatment revenue on patient care, quality improvement, license fees and federal and state taxes. Senate Bill 349, introduced by Sen. Ricardo Lara, D-Bell Gardens, wou ld impose minimum staffing requirements and establish minimum… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - September 6, 2017 Category: Health Management Authors: Scott Rodd Source Type: news

Dialysis bills in California Legislature head to floor for votes
Two bills that would impose increased regulation on dialysis clinics in California are headed to floor votes in both houses of the Legislature. Assembly Bill 251, introduced by Assemblyman Rob Bonta, D-Oakland, would require dialysis clinics to spend at least 85 percent of treatment revenue on patient care, quality improvement, license fees and federal and state taxes. Senate Bill 349, introduced by Sen. Ricardo Lara, D-Bell Gardens, wou ld impose minimum staffing requirements and establish minimum… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 6, 2017 Category: Biotechnology Authors: Scott Rodd Source Type: news

Dialysis bills in Legislature head to floor for votes
Two bills that would impose increased regulation on dialysis clinics in California are headed to floor votes in both houses of the Legislature. Assembly Bill 251, introduced by Assemblyman Rob Bonta, D-Oakland, would require dialysis clinics to spend at least 85 percent of treatment revenue on patient care, quality improvement, license fees and federal and state taxes. Senate Bill 349, introduced by Sen. Ricardo Lara, D-Bell Gardens, wou ld impose minimum staffing requirements and establish minimum… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 6, 2017 Category: Pharmaceuticals Authors: Scott Rodd Source Type: news

Dialysis clinic steps up to ensure vital care in Harvey's aftermath
At one Fresenius Kidney Care center in Houston, the clinic director noticed that one patient waiting for a kidney transplant had a much more immediate need last week, as the city struggled with the aftermath of Hurricane Harvey. The woman needed a ride home from dialysis. Ambulances were tied up rescuing flood victims, and there was a midnight curfew. (Source: CNN.com - Health)
Source: CNN.com - Health - September 4, 2017 Category: Consumer Health News Source Type: news

Association of ESAs and Cancer Risk Among Dialysis Patients Association of ESAs and Cancer Risk Among Dialysis Patients
Erythropoiesis-stimulating agents are commonly used to treat anemia in ESRD patients, but they may be linked to a higher incidence of cancer.Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 1, 2017 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

FDA Fast Tracks New Blood Filtration System
ExThera Medical, a developer of blood filtration systems and biotechnologies, has received Expedited Access Pathway (EAP) designation from FDA for its latest technology, the Seraph 100 blood filter. The EAP designation indicates that the use for the technology will be an adjunctive treatment for bacteremia, in addition to antibiotics for patients receiving hemodialysis when the source of the infection is heparin-binding bacteria. ExThera applied for the EAP designation in June, and the company said FDA granted the designation within an accelerated timeframe. The company said its technology differs from other blood filter s...
Source: MDDI - August 31, 2017 Category: Medical Devices Tags: Business Source Type: news

European Commission Approves Expanded Use Of Mimpara ® (Cinacalcet) For The Treatment Of Secondary Hyperparathyroidism In Children With End-Stage Renal Disease On Dialysis
THOUSAND OAKS, Calif., Aug. 31, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the European Commission (EC) has granted Marketing Authorization of a pediatric formulation (granules in capsule for opening) of Mimpara® (cinacalcet) for the treatment of secondary hyperparathyroidism (HPT) in children aged three years and older with end‑stage renal disease (ESRD) on maintenance dialysis therapy in whom secondary HPT is not adequately controlled with standard of care therapy. "Secondary HPT is a serious and complex condition, and there are currently limited treatment options available for...
Source: Amgen News Release - August 31, 2017 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

How Displaced Texans Who Need Critical Medicine And Care Can Get Help
Despite Harvey, things like insulin shots, antiretrovirals and dialysis can't be interrupted. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - August 31, 2017 Category: Consumer Health News Source Type: news

Vascular access device maker Stent Tek closes Series A
Medical device firm Stent Tek said today it closed an undisclosed Series A financing round to support the development of its ePath AVF minimally invasive catheter technology. The ePath AVF device is designed for vascular access as an alternative to surgical fistulas for hemodialysis patients. Money in the round came from institutional investors Julz and Deepbridge Capital, the London-based company said. Stent Tek has previously received $1.6 million (GBP £1.2 million) in grant funding from the National Institute of Health Research, Innovate UK and the Royal Academy of Engineering Enterprise Hub. “I was thorough...
Source: Mass Device - August 30, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Business/Financial News Stents Vascular stenttek Source Type: news

Exthera Medical wins FDA EAP designation for Seraph 100 blood filter
Exthera Medical said today that the FDA granted its Seraph 100 blood filter an expedited access pathway designation. The approval comes with an initial indication for use “as an adjunctive treatment for bacteremia in addition to antibiotics for patients receiving hemodialysis when the source of the infection is heparin- or heparin sulfate-binding bacteria, including antibiotic resistant bacteria MRSA, VRE, ESBL, CRE and MRSE,” the company said. “We submitted our EAP application in early June. FDA responded by requesting additional information and clarifications, and Seraph was granted EAP designation with...
Source: Mass Device - August 30, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Food & Drug Administration (FDA) Regulatory/Compliance ExThera Medical Source Type: news

Stent Tek Closes Series a Investment Round for its ePATH AVF Device, Aiming to Improve Vascular Access for Haemodialysis
LONDON, August 30, 2017 -- (Healthcare Sales & Marketing Network) -- Stent Tek, a medical device company that is developing a minimally invasive catheter system for dialysis patients, announced today it has successfully closed a Series A funding round wit... Devices, Venture Capital Stent Tek, ePATH AVF, haemodialysis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 30, 2017 Category: Pharmaceuticals Source Type: news

MassDevice.com +5 | The top 5 medtech stories for August 28, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Resonetics acquires Aduro Laser Resonetics announced that it has acquired Aduro Laser. The financial details of the deal were not disclosed. “We are very excited to partner with Grayson Beck and Demian Backs, who have cre...
Source: Mass Device - August 28, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

FDA clears NxStage Medical's System One, allowing for solo home hemodialysis
NxStage Medical, a medical technology outfit focused on advancing renal care, has received clearance from the FDA for its System One, which allows for solo home hemodialysis, without a care partner, during waking hours.   (Source: mobihealthnews)
Source: mobihealthnews - August 28, 2017 Category: Information Technology Source Type: news

NxStage Medical wins expanded FDA nod for System One home hemodialysis system
NxStage Medical (NSDQ:NXTM) said today it won expanded FDA clearance for its System One home hemodialysis system, clearing it for use without a care partner during waking hours. The system won initial clearance in 2005 and added clearance for home nocturnal hemodialysis in 2014, the Lawrence, Mass.-based company said, but has always required a care partner be present during hemodialysis. “Patients have been asking for an FDA-cleared solo option for years,. Many patients have been turned away from home hemodialysis simply because they did not have a care partner.  The ability to train and treat solo provides a br...
Source: Mass Device - August 28, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Food & Drug Administration (FDA) Regulatory/Compliance NxStage Medical Inc. Source Type: news

Bard lands new indication for its drug-coated balloon
C. R. Bard(NYSE:BCR) said today that its Lutonix 035 drug-coated balloon PTA catheter won premarket approval from the FDA and is available in the U.S. The company’s Lutonix 035 device is the first drug-coated balloon approved in end-stage renal disease patients with stenotic lesions in dialysis arteriovenous fistulae. Bard’s DCB is also approved to treat superficial femoral artery and popliteal artery disease. Get the full story at our sister site, Drug Delivery Business News. The post Bard lands new indication for its drug-coated balloon appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - August 28, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Pharmaceuticals Regulatory/Compliance Vascular Wall Street Beat crbard Source Type: news

NxStage Medical Announces FDA Clearance for Solo Home Hemodialysis Using NxStage(R) System One(TM)
First clearance of its kind gives trained NxStage patients freedom to dialyze without a care partner LAWRENCE, Mass., Aug. 28, 2017 -- (Healthcare Sales & Marketing Network) -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company... Devices, FDA NxStage Medical, System One, home hemodialysis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 28, 2017 Category: Pharmaceuticals Source Type: news

The Effects of Short Sleep Duration on Proteinuria and CKD The Effects of Short Sleep Duration on Proteinuria and CKD
Are short sleepers at a higher risk of developing proteinuria and chronic kidney disease?Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 25, 2017 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Eleven-Year-Old Boy Receives Kidney for Christmas at Duke
Treatment TermsPediatric Kidney Transplant Author Hallie Potocki Overview After battling kidney disease his entire young life, 11-year-old Kaleek Beatty got the best present he could ask for, just five days before Christmas 2016. Duke Children's Hospital called to say they had found a kidney for him. Hero Imagekaleekbeatty_blog.jpg Preview Image Content Blocks Header Born with Kidney Disease ContentAsk a typical 11-year-old, “What do you want to be when you grow up?” and you’re likely to hear “sports superstar” or “rock musician.” Ask Kaleek Beatty, though, and his u...
Source: dukehealth.org: Duke Health News - August 24, 2017 Category: Consumer Health News Authors: mf205 at duke.edu Source Type: news

Angola: Cuando Cubango General Hospital Unveiled
[ANGOP] Menongue -The new General Hospital of the southern Cuando Cubango province, fully equipped with high technological equipment to serve various services, especially hemodialysis, was inaugurated on Saturday by the Health Minister, Lu ís Gomes Sambo. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 21, 2017 Category: African Health Source Type: news

‘ 07 to ‘ 14 Saw Drop in Proportion Needing Dialysis After TAVI
Need for new dialysis after TAVI linked to increased risk of mortality at 30 - days and four years (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - August 16, 2017 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Geriatrics, Internal Medicine, Nephrology, Nursing, Pathology, Pulmonology, Surgery, Journal, Source Type: news

New research shows promise for improving vascular access for hemodialysis patients
(Elsevier) Hemodialysis requires repeated access to the blood. Failure to maintain adequate access to the vasculature is a major cause of medical complications and, potentially, death for these patients. A new study in The American Journal of Pathology provides information about the mechanisms underlying failure of the most common type of hemodialysis vascular access, the arteriovenous fistula. Despite being the preferred approach, there is currently limited understanding of the mechanisms involved in fistula maturation failure. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 16, 2017 Category: International Medicine & Public Health Source Type: news

VentureMed raises $15m in Series B
Vascular focused device developer VentureMed said today it raised $15 million in a Series B round. The round was led by newly invested Endeavour Vision and joined by RiverVest Venture Partners, the Toledo, Ohio-based company said. “Endeavour Vision’s current fund is dedicated to transformational technologies in medical devices and digital health. We are excited to support a company with the potential to make significant improvements in the lives of millions of men and women globally who suffer from peripheral vascular diseases and others suffering from the challenging management of renal dialysis access,”...
Source: Mass Device - August 15, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News venturemed Source Type: news

How a political fight over regulation of dialysis clinics may reduce UC Davis research funding
Nonprofit Dialysis Clinics Inc. set aside $550,000 for kidney disease research last year. The dialysis provider argues that recently proposed requirements for dialysis clinics would jeopardize its ability to devote funds to research. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - August 11, 2017 Category: Health Management Authors: Scott Rodd Source Type: news

How a political fight over regulation of dialysis clinics may reduce UC Davis research funding
Nonprofit Dialysis Clinics Inc. set aside $550,000 for kidney disease research last year. The dialysis provider argues that recently proposed requirements for dialysis clinics would jeopardize its ability to devote funds to research. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 11, 2017 Category: Biotechnology Authors: Scott Rodd Source Type: news

Fighting for the right to nurse
As a teenager Emily Heron had her career all mapped out – and it was quite unusual. Emily planned to be an aeronautical engineer with the RAF. She had completed an engineering diploma (the only female to do so at that time) and was taking A’ Levels with a view to embarking on officer training in the Air Force. She was a young woman on a mission. But then her life took a completely different turn. Five years ago Emily’s father was diagnosed with chronic kidney disease. He would need to go on dialysis. And his condition and its treatment were compounded by mental health issues. Emily wasn’t living at ...
Source: UNISON Health care news - August 11, 2017 Category: UK Health Authors: Demetrios Matheou Tags: Magazine 2017 Health Care Service Group Conference fighting cuts and privatisation in the NHS NHS bursary save the NHS bursary student nurses Source Type: news

WATCH: California man to get lifesaving kidney donation
Michael Hermogeno suffers from severe heart disease and has been on dialysis and waiting for a transplant for nearly a year. (Source: ABC News: Health)
Source: ABC News: Health - August 9, 2017 Category: Consumer Health News Tags: Health Source Type: news

MassDevice.com +5 | The top 5 medtech stories for August 7, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. How slugs are creating better medical adhesives Slug mucus is the inspiration behind a new adhesive to close surgical wounds and reduce the use of surgical staples, according to new research out of Harvard. Some of the current ...
Source: Mass Device - August 7, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Fresenius Medical Care agrees $2bn deal to buy NxStage
Acquisition will help German group push further into home dialysis treatment (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - August 7, 2017 Category: Pharmaceuticals Source Type: news

Fresenius/NxStage: dialysis analysis
Renal specialist agrees a strategically sensible but expensive takeover (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - August 7, 2017 Category: Pharmaceuticals Source Type: news

Fresenius to pay $2B for NxStage Medical
Fresenius Medical Care (NYSE:FMS; ETR:FRE) said today that it agreed to pay $2 billion to acquire NxStage Medical (NSDQ:NXTM) and the home hemodialysis technology it developed. The $30-per-share deal, which is expected to close this year, represents a 29.6% premium on the August 4 closing price of $23.14 for NXTM shares. The stock was up 25.5% to $29.04 today in pre-market trading. FRE shares were down -1.2% to €69.14 apiece today in Frankfurt. Fresenius said it plans to fund the deal with cash and debt and expects Lawrence, Mass.-based NxStage to add to net income and earnings per share within three ye...
Source: Mass Device - August 7, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Dialysis Mergers & Acquisitions Wall Street Beat Fresenius Medical Care NxStage Medical Inc. Source Type: news

Fresenius to buy Lawrence-based ​NxStage Medical for $2B
NxStage Medical Inc., a Lawrence-based medical device maker that largely pioneered the market for home hemodialysis, will be acquired for $2 billion by Fresenius Medical Care, a German dialysis giant with its North American headquarters in Waltham. The purchase price of $30 per share represents a 30 percent increase from NxStage’s (Nasdaq: NXTM) closing share price on Friday, and is 22 percent higher than the company’s 90-day moving average share price, according to Reuters. NxStage shares were… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 7, 2017 Category: American Health Authors: Don Seiffert Source Type: news